Key Points
Short seller alleges Gildan inflated sales through channel stuffing for years.
Stock fell 18.75% to $70.39 CAD, erasing $3 billion in market value.
Jehoshaphat forecasts 20% revenue miss in H2 2026 and $500 million product overhang.
Multiple law firms launched securities fraud investigations on June 16.
Shares of Gildan Activewear dropped 18.75% to $70.39 CAD on June 16 after short seller Jehoshaphat Research alleged the Montreal-based T-shirt maker inflated sales through channel stuffing. The stock fell as much as 25% during the day, wiping $3 billion from the company’s $13 billion market value. Gildan denied the allegations but offered no detailed rebuttal, citing a policy of not commenting further.
What Jehoshaphat Alleged
Jehoshaphat Research claimed Gildan pushed excess inventory to distributors and retailers beyond what they could realistically sell to inflate quarterly revenue. The report alleged this practice has been ongoing for years and is now running out of room to continue. Jehoshaphat interviewed seven former employees, customers, or distributors and conducted accounting analysis. The firm forecasts Gildan will miss analyst sales estimates by 20% in the second half of 2026 and estimated a $500 million product overhang from channel stuffing.
How the Firm Operates
Jehoshaphat Research holds a short position worth 4% of Gildan’s public float, meaning it profits if the stock falls. The Florida-based firm has a track record in Canada. In September 2025, it published a report on subprime lender goeasy Ltd. alleging hidden loan losses. Months later, goeasy announced surging loan losses and suspended its dividend. That stock has fallen 75% over the past year.
Gildan’s Response and Guidance
Gildan stated it is confident its current disclosure provides accurate and comprehensive financial information. The company reiterated its fiscal 2026 guidance of US$6 billion to US$6.2 billion in revenue and free cash flow above US$850 million. The company declined to address the allegations directly and said it will not provide further comments.
Legal Action Begins
Multiple law firms launched securities fraud investigations on June 16. Block & Leviton and Rosen Law Firm are investigating whether Gildan committed securities violations through misleading business disclosures. These firms are seeking to represent investors who lost money and may file class action lawsuits to recover losses on behalf of shareholders.
Final Thoughts
Gildan faces severe credibility damage and legal exposure. With the stock down 19% and fraud investigations underway, investors should monitor Q2 earnings closely to verify whether revenue meets guidance or confirms Jehoshaphat’s 20% miss forecast.
FAQs
Channel stuffing occurs when companies push excess inventory to distributors or retailers beyond realistic sales capacity to artificially inflate revenue figures.
Gildan shares dropped 18.75% to $70.39 CAD, falling as much as 25% intraday and erasing approximately $3 billion in market capitalization.
Jehoshaphat published a report on goeasy Ltd. in September 2025 alleging hidden loan losses. Months later, goeasy suspended dividends and stock fell 75% annually.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
About Author

Danny Kontos
Co FounderDanny Kontos has been a stock investor since 2007 and co-founded Meyka in 2023. He keeps a small, focused portfolio and only moves when the numbers are hard to argue with. He has waited years on a single position before. Before Meyka, he ran a web hosting company and a mortgage lending platform, so he knows what a well-run business actually looks like under the hood. This article did not come from a news cycle. It came from someone who has been watching this space for a long time.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)